Zelal Kharaba

1.4k total citations · 1 hit paper
72 papers, 598 citations indexed

About

Zelal Kharaba is a scholar working on Geriatrics and Gerontology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Zelal Kharaba has authored 72 papers receiving a total of 598 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Geriatrics and Gerontology, 9 papers in Biomaterials and 9 papers in Biomedical Engineering. Recurrent topics in Zelal Kharaba's work include Pharmaceutical Practices and Patient Outcomes (13 papers), Nanoparticle-Based Drug Delivery (8 papers) and Antibiotic Use and Resistance (7 papers). Zelal Kharaba is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (13 papers), Nanoparticle-Based Drug Delivery (8 papers) and Antibiotic Use and Resistance (7 papers). Zelal Kharaba collaborates with scholars based in United Arab Emirates, United Kingdom and Jordan. Zelal Kharaba's co-authors include Ghulam Murtaza, Manal Buabeid, Badriyah S. Alotaibi, Munazza Ijaz, Abbas Rahdar, Yassen Alfoteih, Sonia Fathi‐karkan, Feras Jirjees, Hafiza Sidra Yaseen and Ahmad Al‐Azayzih and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Zelal Kharaba

64 papers receiving 578 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Revolutionizing prostate cancer therapy: Artificial intelligence – Based nanocarriers for precision diagnosis and treatment

2025 24 citations Abbas Rahdar, Sonia Fathi‐karkan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zelal Kharaba United Arab Emirates	14	86	80	77	74	60	72	598
Fiaz Ahmad Pakistan	11	61 0.7×	61 0.8×	49 0.6×	141 1.9×	46 0.8×	18	569
Deepti Chopra India	16	54 0.6×	130 1.6×	34 0.4×	35 0.5×	33 0.6×	64	756
Kifayat Ullah Shah Pakistan	22	105 1.2×	215 2.7×	53 0.7×	241 3.3×	51 0.8×	66	1.3k
Sandhiya Selvarajan India	17	101 1.2×	208 2.6×	88 1.1×	91 1.2×	69 1.1×	80	1.0k
Syed Arman Rabbani United Arab Emirates	13	58 0.7×	136 1.7×	26 0.3×	54 0.7×	22 0.4×	79	654
Zhila Taherzadeh Iran	20	76 0.9×	168 2.1×	45 0.6×	118 1.6×	18 0.3×	48	1.0k
Chandra Bhushan Tripathi India	15	25 0.3×	83 1.0×	86 1.1×	44 0.6×	24 0.4×	50	646
Mehrukh Zehravi Saudi Arabia	17	124 1.4×	244 3.0×	75 1.0×	97 1.3×	66 1.1×	78	1.1k
Hussain Ali Pakistan	13	26 0.3×	115 1.4×	40 0.5×	41 0.6×	47 0.8×	35	461
Sami El Khatib Lebanon	11	60 0.7×	66 0.8×	28 0.4×	20 0.3×	22 0.4×	78	518

Countries citing papers authored by Zelal Kharaba

Since Specialization

Citations

This map shows the geographic impact of Zelal Kharaba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zelal Kharaba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zelal Kharaba more than expected).

Fields of papers citing papers by Zelal Kharaba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zelal Kharaba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zelal Kharaba. The network helps show where Zelal Kharaba may publish in the future.

Co-authorship network of co-authors of Zelal Kharaba

This figure shows the co-authorship network connecting the top 25 collaborators of Zelal Kharaba. A scholar is included among the top collaborators of Zelal Kharaba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zelal Kharaba. Zelal Kharaba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abuhelwa, Ahmad Y., Ethan Basch, Humaid O. Al‐Shamsi, et al.. (2025). Predictive and Prognostic Significance of Patient‐Reported Outcomes for Survival and Adverse Events in Daratumumab‐Treated Multiple Myeloma. European Journal Of Haematology. 114(6). 1020–1031.

Abuhelwa, Ahmad Y., Jennifer R. Brown, Humaid O. Al‐Shamsi, et al.. (2025). Statin use and survival in CLL/SLL treated with ibrutinib: pooled analysis of 4 randomized controlled trials. Blood Advances. 9(14). 3566–3575. 1 indexed citations

Kharaba, Zelal, Ahmad Al‐Azayzih, Sayer Al‐Azzam, et al.. (2025). Barriers to effective communication in UAE community pharmacies: general public perspectives on enhancing patient-pharmacist interaction and policy development. Journal of Pharmaceutical Policy and Practice. 18(1). 2460744–2460744.

Rahdar, Abbas, et al.. (2025). Nanorobotics in Precision Surgery: The Future of Minimally Invasive Procedures. Nano LIFE. 1 indexed citations

Pourmadadi, Mehrab, Rabia Arshad, Zelal Kharaba, et al.. (2024). Polymeric and non-polymeric oxaliplatin nanomedicine for cancer therapy: A comprehensive review. European Polymer Journal. 208. 112870–112870. 12 indexed citations

Arshad, Rabia, Dilawar Hassan, Abbas Rahdar, et al.. (2024). Nano-engineered solutions for ibuprofen therapy: Unveiling advanced co-delivery strategies and nanoparticle systems. Journal of Drug Delivery Science and Technology. 98. 105815–105815. 7 indexed citations

Sadr, Soheil, et al.. (2024). Exploring the integration of nanotechnology in the development and application of biosensors for enhanced detection and monitoring of colorectal cancer. Inorganic Chemistry Communications. 164. 112409–112409. 21 indexed citations

Kharaba, Zelal, Yassen Alfoteih, Feras Jirjees, et al.. (2024). Assessment of knowledge and awareness of stroke among the Syrian population: unveiling the current landscape in Syria through the first nationally representative study. Scientific Reports. 14(1). 15426–15426. 1 indexed citations

Jarab, Anan S., Walid Al‐Qerem, Tareq L. Mukattash, et al.. (2024). Factors Influencing Public Attitudes and Willingness to Utilize Telepharmacy Services in the UAE. International Journal of Telemedicine and Applications. 2024(1). 5755493–5755493.

10.

Hoseini, Zakieh Sadat, et al.. (2024). Cell-targeting nanomedicine for bladder cancer: A cellular bioengineering approach for precise drug delivery. Journal of Drug Delivery Science and Technology. 101. 106220–106220. 6 indexed citations

11.

Sadr, Soheil, Abbas Rahdar, Sadanand Pandey, et al.. (2024). Gold nanobiosensors and Machine Learning: Pioneering breakthroughs in precision breast cancer detection. SHILAP Revista de lepidopterología. 12. 100238–100238. 5 indexed citations

12.

Aman, Waqar, Rabia Arshad, Abbas Rahdar, et al.. (2024). Progression in nano-botanical oral hygiene solutions: The Dawn of biomimetic nanomaterials. SHILAP Revista de lepidopterología. 12. 100219–100219. 4 indexed citations

13.

Kharaba, Zelal, Anan S. Jarab, Walid Al‐Qerem, et al.. (2023). What factors shape public knowledge, attitudes, and practices of corticosteroid use in the UAE during the COVID-19 pandemic?. Electronic Journal of General Medicine. 21(1). em559–em559. 1 indexed citations

14.

Bakhshi, Ali, Annu Pandey, Zelal Kharaba, et al.. (2023). Microfluidic-based nanoplatforms for cancer theranostic applications: A mini-review on recent advancements. OpenNano. 15. 100197–100197. 8 indexed citations

15.

Al‐Azayzih, Ahmad, et al.. (2023). Prevalence and Associated Predictors of Inappropriate and Omitted Medications Prescribing in Older Patients with Advanced Cancer: A Cross-Sectional Study. Clinical Interventions in Aging. Volume 18. 1653–1661.

16.

Said, Amira S. A., et al.. (2023). Clinical Consequences for Individuals Treated with Tocilizumab for Serious COVID-19 Infection. Healthcare. 11(4). 607–607. 6 indexed citations

17.

Al‐Azayzih, Ahmad, et al.. (2023). Anticholinergic burden risk and prevalence of medications carrying anticholinergic properties in elderly cancer patients in Jordan. Saudi Pharmaceutical Journal. 31(9). 101710–101710. 2 indexed citations

18.

Barakat, Muna, Mohamed Hassan Elnaem, Doaa H. Abdelaziz, et al.. (2023). Assessment of Knowledge, Perception, Experience and Phobia toward Corticosteroids Use among the General Public in the Era of COVID-19: A Multinational Study. Healthcare. 11(2). 255–255. 12 indexed citations

19.

Kharaba, Zelal, Rose Ghemrawi, Ahmad Z. Al Meslamani, et al.. (2022). Caffeine Consumption among Various University Students in the UAE, Exploring the Frequencies, Different Sources and Reporting Adverse Effects and Withdrawal Symptoms. Journal of Nutrition and Metabolism. 2022. 1–7. 18 indexed citations

20.

Kharaba, Zelal, Sayer Al‐Azzam, Ahmed Alhusban, & Khawla Nuseir. (2021). A look behind the scenes: COVID-19 impact on depression and perceived stress of UAE population. Middle East Current Psychiatry. 28(1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact